Sigyn Therapeutics, Inc. Annual report pursuant to Section 13 and 15(d)

COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)		1 Months Ended	12 Months Ended
	Jun. 01, 2017	Dec. 31, 2016	Dec. 31, 2017	Dec. 31, 2016	Dec. 02, 2016
Rent expense				$ 95,603
Successor [Member]
Total rent			$ 3,200
Rent expense			99,679
Monthly sub leased		$ 7,834	7,834
Estimated fair value of contingent payments, net		$ 424,511	287,957	424,511
Reimbursement Expenses			53,486
Contingent cash payment					$ 500,000
Predecessor [Member]
Earn out payments			41,534
Reimbursement Expenses				$ 95,020
ASK Gold [Member] \| Successor [Member]
Earn out payments			41,534
ASK Gold [Member] \| Predecessor [Member]
Earn out payments			$ 83,068
Third Party [Member] \| Successor [Member]
Monthly sub leased	$ 4,000